Mechanistic Evaluation of LolA and β ‐Sliding Clamp Inhibition by Silybin and Diclofenac as Gentamicin Adjuvants Against Enteropathogenic Escherichia coli
Open Access
- 1 January 2026
- journal article
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 5624539
Abstract
To address the challenges of antimicrobial resistance, one potential approach is to repurpose existing drugs. In the current study, structurally distinct antibiotics were combined with the repurposed drugs silybin and diclofenac to evaluate the potential of these combinations against resistant bacterial strains. The investigation encompassed in vitro determination of the minimum inhibitory concentration (MIC) and time‐kill kinetics, as well as in vivo assessments of percentage change in body weight, total white blood cell (WBC) count, colitis and edema, histopathological changes, stool scores, and blood culture in an enteropathogenic Escherichia coli (EPEC)‐infected mouse model. Both silybin and diclofenac potentiated the activity of several antibiotics, with gentamicin showing the most promising results. The gentamicin–silybin (Gen + Sily) and gentamicin–diclofenac (Gen + Dic) combinations not only demonstrated sustained antibacterial activity in the time‐kill assay compared with gentamicin monotherapy but also provided greater protection against crypt cell damage and more effectively alleviated colitis and edema in the EPEC‐infected mouse model. In silico molecular docking and 250‐ns molecular dynamics simulations hypothesized two potential targets implicated in antibiotic adjuvant activity: LolA and the β ‐sliding clamp protein. Molecular docking and MM/PBSA analyses indicated that silybin and diclofenac exhibited stronger binding affinities and more favorable total binding free energies toward LolA and the β ‐sliding clamp protein, respectively, than the corresponding reference compounds.Keywords
Funding Information
- Ministry of Science and Technology, Government of the People’s Republic of Bangladesh (825)
- Ministry of Science and Technology, Government of the People’s Republic of Bangladesh (413)
This publication has 74 references indexed in Scilit:
- Advances in Small Molecule Inhibitors Targeting the Bacterial Lipoprotein Transport System (Lol) in Gram‐Negative BacteriaChemistry – An Asian Journal, 2025
- Diclofenac Resensitizes Methicillin‐Resistant Staphylococcus aureus to β‐Lactams and Prevents Implant InfectionsAdvanced Science, 2021
- Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarinMedicinal Research Reviews, 2021
- Clinical hematological and biochemical parameters in Swiss, BALB/c, C57BL/6 and B6D2F1 Mus musculusAnimal Models and Experimental Medicine, 2020
- CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR dataJournal of Computational Chemistry, 2013
- Synergistic effects between silibinin and antibiotics on methicillin‐resistant Staphylococcus aureus isolated from clinical specimensBiotechnology Journal, 2011
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspectiveElectrophoresis, 2009
- Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)Journal of Computational Chemistry, 1999
- LINCS: A linear constraint solver for molecular simulationsJournal of Computational Chemistry, 1997